HomeNDC LookupIngredientsMinoxidil › 84355-0004-01
🧴image loading
(from DailyMed)

5%Minoxidil Hair Growth Sprays Serum 5 g/100mL Liquid

by Guangzhou Binsi Clothing Co.,Ltd. · 1 BOTTLE in 1 BOX (84355-004-01) / 60 mL in 1 BOTTLE
NDC 84355-0004-01
🏷️ FDA NDC (as labeled) 84355-004-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 6, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 84355-004-01
Product NDC 84355-004
11-digit billing NDC 84355000401
RxCUI 1537948
UNII 5965120SH1
Application # 505G(a)(3)
SPL Set ID 2f7f3b80-48d8-9e24-e063-6394a90a43f5
Established class (EPC) Arteriolar Vasodilator
Physiologic effect Arteriolar Vasodilation
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-03-04
Route TOPICAL
Dosage form LIQUID
Substance MINOXIDIL
Why two NDCs? The FDA registers this code as 84355-004-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84355-0004-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Arteriolar Vasodilator class.

Pharmacologic class Arteriolar Vasodilator
Drug family (ATC) Pyrimidine derivatives, Other dermatologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerGuangzhou Binsi Clothing Co.,Ltd.
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code84355
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • That's a really common question. Minoxidil tablets are very effective at lowering blood pressure, but they cause two side effects that need to be managed: your heart speeds up, and...
  • I've been prescribed minoxidil tablets for blood pressure — why do I need to take other pills with it?
  • It takes patience — most people need at least 2 to 4 months of twice-daily use before they notice any regrowth. Some products note that results can start appearing around the 2-mon...
  • I'm using a topical minoxidil solution for hair loss. How long before I see results?
📖 Read our full Minoxidil guide →
1
Nutrient depletion considerations

Minoxidil may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 3XUS85K0RA
    Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
  • UNII 3G6A5W338E
    Caffeine is a natural stimulant compound commonly extracted from coffee beans and tea leaves. In medicines, it serves as an active booster in pain relievers and cold products to enhance alertness and improve the effectiveness of other ingredients.
  • UNII I6OER6U04L
    A plant extract from chrysanthemum flowers used as a natural colorant and flavoring agent in medicines. It may contribute mild taste or visual appeal to the final product.
  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII 7E6SK9QDT8
    Cyclodextrins are ring-shaped sugar molecules derived from starch. They're used in medicines as solubilizers to help poorly dissolving drugs dissolve better, and sometimes as binders or stabilizers.
  • UNII 25KRT26H77
    A synthetic organic compound used as a preservative and antioxidant in medicines. It helps prevent breakdown and spoilage of the active ingredients during storage.
  • UNII L7T10EIP3A
    A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
  • UNII 25X51I8RD4
    Niacinamide is a form of vitamin B3, a water-soluble nutrient. In medicines, it may be added as a nutritional supplement or to support skin health, though its primary role here is as an active ingredient rather than a traditional inactive filler.
  • UNII 3Z3866YW6P
    A plant extract from peony root used in traditional herbal formulations. It may function as a flavoring agent, natural colorant, or botanical ingredient to support the product's herbal composition.
  • UNII BUG255FE7X
    A plant-derived ingredient from tree peony root bark. It's used in traditional formulations as a natural filler and may help stabilize the medicine's consistency and appearance.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 8LGU7VM393
    Rosemary leaf oil is a natural aromatic oil extracted from rosemary plants. It's used in medicines as a flavoring agent and preservative to help protect the product from spoilage.

14 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesPROPYLENE GLYCOL AQUA ALCOHOL BUTYLENE GLYCOL CAFFEINE NIACINAMIDE CITRIC ACID ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL CYCLODEXTRIN MENTHOLUM HYDROXYPHENYL PROPAMIDOBENZOIC ACID PAEONIA SUFFRUTICOSA ROOT BARK EXTRACT PAEONIA ALBIFLORA ROOT EXTRACT CHRYSANTHEMUM INDICUM FLOWER EXTRACT

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
equate hair regrowth treatment 5 g/100mL 49035-0746-16 Wal-Mart 1 bottle FDA listed
Elevate Hair Growth Serum 5 g/100mL 81653-0010-01 Guangzhou 60 ml FDA listed
Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0024-01 Shenzhen 60 ml FDA listed
Hair regrowth treatment 5 g/100mL 81653-0005-01 Guangzhou 3 bottles FDA listed
Minoxidil Hair Growth Serum 5 g/100mL 85092-0001-01 Shenzhen 1 bottle Discontinued
5% MINOXIDIL TOPICAL Solution 5 g/100mL 85174-0001-02 Nanhong 2 bottles Discontinued
5% Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0023-01 Shenzhen 60 ml FDA listed
Leader Minoxidil 5 g/100mL 70000-0653-01 Cardinal 3 bottles FDA listed
hims hair regrowth treatment 5 g/100mL 71730-0000-16 Hims 1 bottle FDA listed
Hair Beardgrowth Foam 5 g/100mL 85173-0001-01 Shenzhen 60 ml FDA listed
Good Sense Hair Regrowth Treatment 5 g/100mL 00113-1032-30 L. 3 bottles FDA listed
hair regrowth treatment 5 g/100mL 00363-0032-16 Walgreen 1 bottle FDA listed
equate hair regrowth treatment 5 g/100mL 79903-0222-01 WALMART 1 bottle FDA listed
minoxidil 5 g/100mL 56062-0322-16 Publix 1 bottle FDA listed
hair regrowth treatment 5 g/100mL 41250-0428-30 Meijer, 3 bottles FDA listed
kirkland signature minoxidil 5 g/100mL 63981-0032-40 Costco 6 bottles FDA listed
hair regrowth treatment 5 g/100mL 11822-1260-00 Rite 1 bottle FDA listed
hair regrowth treatment 5 g/100mL 30142-0632-30 Kroger 3 bottles FDA listed
Soti Hair Growth Serum 5 g/100mL 81653-0013-01 Guangzhou 60 ml FDA listed
minoxidil 5 g/100mL 37808-0833-16 H 1 bottle FDA listed
members mark hair regrowth treatment 5 g/100mL 68196-0032-40 Sam's 6 bottles FDA listed
OLIVITA Minoxidil 5 g/100mL 83818-0031-01 Shenzhen 60 ml FDA listed
Hair Regen Hair Growth Treatment 5 g/100mL 84232-0001-01 YIWUYIZHOUTRADINGCO.,LTD 60 ml FDA listed
Minoxidil Hair Growth Serum 5 g/100mL 85741-0004-01 Shenzhen 1 bottle FDA listed
hair regrowth treatment 5 g/100mL 21130-0611-16 Safeway 1 bottle FDA listed
signature care hair regrowth treatment 5 g/100mL 21130-0819-16 Safeway 1 bottle Discontinued
minoxidil 5 g/100mL 71713-0094-16 THIRTY 1 bottle FDA listed
Minoxidil Extra Strength for Men 5 g/100mL 72484-0095-03 Roman 1 bottle FDA listed
VENANOCI Minoxidil 5 g/100mL 83818-0029-01 Shenzhen 60 ml FDA listed
Hair-Regen Hair Growth Treatment 5 g/100mL 84232-0011-26 Yiwu 6 bottles FDA listed
Hair Growth Serum Roll-ON 5 g/100mL 85524-2625-02 FlexiGo 1 bottle FDA listed
LILIVERA Hair Regrowth Kit 5 g/100mL 60771-0012-01 Guangzhou 60 ml FDA listed
basic care hair regrowth treatment 5 g/100mL 72288-0798-16 Amazon.com 60 ml FDA listed
up and up hair regrowth treatment for men 5 g/100mL 11673-0317-30 Target 3 bottles FDA listed
Psalmonica Hair Growth Serum 5 g/100mL 60771-0013-01 Guangzhou 60 ml FDA listed
Hair Regrowth Treatment 5 g/100mL 69842-0598-16 CVS 1 bottle FDA listed
5%Minoxidil Hair Growth Serum 5 g/100mL 84355-0003-01 Guangzhou 1 bottle FDA listed
5%Minoxidil Hair Growth Sprays Serum 5 g/100mLthis 84355-0004-01 Guangzhou 1 bottle FDA listed
Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0031-01 Shenzhen 100 ml FDA listed
Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0032-01 Shenzhen 60 ml FDA listed
Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0033-01 Shenzhen 100 ml FDA listed
ValBello 5 g/100mL 87942-0001-01 ValBello 125 ml FDA listed
Hair Regrowth Treatment 5 g/100mL 72288-0667-40 Amazon.com 6 bottles FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed

The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Minoxidil (matched by generic name) — the program that covers self-administered drugs. 3 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Minoxidil. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.5M
Claims incl. refills
260.9K
Beneficiaries
202.1K
Spend / beneficiary
$17.33
Spend / claim
$13.42
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Minoxidil — the ingredient across all brands.

Top reported reactions

Adverse Drug Reaction8,585
Alopecia3,803
Application Site Pruritus2,926
Overdose1,461
Application Site Irritation1,420
Application Site Pain1,413
Hair Texture Abnormal1,409

Reporter sex

44,697 reports
Male · 58%
Female · 42%
Unknown · 0%
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 8,466 973
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
84355-0004-01 You're viewing this 1 BOTTLE in 1 BOX (84355-004-01) / 60 mL in 1 BOTTLE 2025-03-04 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 84355-004-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 84355-0004-01, written without dashes as 84355000401. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 84355-0004-01, the first segment (84355) is the labeler code FDA assigned to Guangzhou Binsi Clothing Co.,Ltd.; the middle segment (0004) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Guangzhou Binsi Clothing Co.,Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Guangzhou Binsi Clothing Co.,Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 7 words

Use to regrow hair on the scalp

⏱️ Dosage and Administration 52 words

use the dropper to apply a few drops to areas of hair loss on the scalp. Gently massage with fingertips for 3-5 minutes until fully absorbed. using more product or applying it more frequently will not improve results. Continued use is required to help maintain hair regrowth; otherwise, hair loss may resume.

⚠️ Warnings 4 words

For external use only.

🧪 Active Ingredient 2 words

Minoxidil 5%

🧪 Inactive Ingredients 33 words

PROPYLENE GLYCOL AQUA ALCOHOL BUTYLENE GLYCOL CAFFEINE NIACINAMIDE CITRIC ACID ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL CYCLODEXTRIN MENTHOLUM HYDROXYPHENYL PROPAMIDOBENZOIC ACID PAEONIA SUFFRUTICOSA ROOT BARK EXTRACT PAEONIA ALBIFLORA ROOT EXTRACT CHRYSANTHEMUM INDICUM FLOWER EXTRACT

🎯 Purpose 3 words

Hair regrowth treatment

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.